Evidences are concordant in reporting that cognitive impairment is significantly associated with Aβ42 in the early phases of AD, whereas the association is more robust with tau and p-tau in the later, MCI phase [91,94,95]. This evidence concerns the gene MAPT and Alzheimer disease.